Nucleic Acid-Based Vaccines
DBCAT005632Pharmacologic class
Vaccines formulated with nucleic acids specific for a target antigen. They are designed to induce antibody production against the target by host. A DrugBank category of 17 drugs. 6 of them are approved.
What you can answer from here — as of January 13, 2022
Which targets do Nucleic Acid-Based Vaccines share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account